Drugs Made In America Acquisition II Corp. Unit (DMIIU)
NASDAQ: DMIIUUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
DMIIU stock chart
Technical analysisKey statistics
All statistics- Dividend yield
- None
- 52-week range
- 9.96 – 10.80
- Day range
- 10.20 – 10.20
- Volume / Avg
- 100 / 389
- Beta
- —
52-week range
DMIIU stock today
Drugs Made In America Acquisition II Unit (DMIIU) closed at $10.20 on Oct 8, down 0.49% (-$0.0499), versus the S&P 500's 0.47% decline. Trading was light, with 100 shares changing hands, about 26% of the average daily volume. At this level, DMIIU sits in the middle of its 52-week range of $9.96 to $10.80: 5.6% below the high, set on Feb 3, 2026 and 2.4% above the low.
DMIIU is up 1.8% year to date, underperforming the S&P 500 (+13.5%). Over the past 12 months, the stock has gained 2.4%.
Summary generated from market data by MetaCap's automated system. Methodology
About Drugs Made In America Acquisition II Unit
Company profile- Headquarters
- New York, NY
- IPO year
- 2025
Drugs Made In America Acquisition II Unit stock FAQ
What is Drugs Made In America Acquisition II Unit's stock price today?
DMIIU last traded at $10.20 as of Oct 8, 4:00 PM EDT, down 0.49% on the day. Prices are delayed at least 15 minutes.
What is the DMIIU 52-week high?
The 52-week high for DMIIU is $10.80 and the 52-week low is $9.96. The stock is currently 5.6% below its high.